Gamma-glutamyl transpeptidase: Redox regulation and drug resistance

Advances in Cancer Research

Volumn 122, Issue , 2014, Pages 103-141

  Hanigan, Marie H ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cysteine; Gamma glutamyl transferase; Gamma glutamyl transpeptidase; Glutathione

Indexed keywords

AMINO ACID; CELL ENZYME; CYSTEINE; CYSTINE; ENZYME INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCINE; OXIDIZING AGENT; OXYGEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATALYST; CELL SURFACE; DRUG RESISTANCE; ENZYME INHIBITION; GLUTATHIONE METABOLISM; HUMAN; HUMAN GENOME; HYDROLYSIS; INTERSTITIAL FLUID; KIDNEY CARCINOMA; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; OVARY ADENOCARCINOMA; OVERALL SURVIVAL; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN DEPLETION; PROTEIN EXPRESSION; REDOX REGULATION; REDOX STRESS; TUMOR PROMOTION; UNTRANSLATED REGION; ANIMAL; BLOOD; CATALYSIS; CHEMISTRY; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; NEOPLASMS; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY; RAT;

ANIMALS; CATALYSIS; CYSTINE; DRUG RESISTANCE, NEOPLASM; GAMMA-GLUTAMYLTRANSFERASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; HUMANS; MICE; NEOPLASMS; OXIDANTS; OXIDATION-REDUCTION; OXYGEN; RATS;

EID: 84902978991     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-420117-0.00003-7     Document Type: Chapter

References (181)

1. Ahmad S., Okine L., Wood R., Aljian J., Vistica D.T. gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents. Journal of Cellular Physiology 1987, 131(2):240-246.
2. Anders M.W., Dekant W. Glutathione-dependent bioactivation of haloalkenes. Annual Review of Pharmacology and Toxicology 1998, 38:501-537.
3. Anderson M.E., Bridges R.J., Meister A. Direct evidence for inter-organ transport of glutathione and that the non-filtration renal mechanism for glutathione utilization involves gamma-glutamyl transpeptidase. Biochemical and Biophysical Research Communications 1980, 96(2):848-853.
4. Auman J.T., Church R., Lee S.Y., Watson M.A., Fleshman J.W., McLeod H.L. Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation. European Journal of Cancer 2008, 44(12):1754-1760.
5. Bachhawat A.K., Thakur A., Kaur J., Zulkifli M. Glutathione transporters. Biochimica et Biophysica Acta 2013, 1830(5):3154-3164.
6. Bailey H.H., Gipp J.J., Mulcahy R.T. Increased expression of gamma-glutamyl transpeptidase in transfected tumor cells and its relationship to drug sensitivity. Cancer Letters 1994, 87(2):163-170.
7. Bailey H.H., Ripple G., Tutsch K.D., Arzoomanian R.Z., Alberti D., Feierabend C., et al. Phase I study of continuous-infusion L-S, R-buthionine sulfoximine with intravenous melphalan. Journal of the National Cancer Institute 1997, 89(23):1789-1796.
8. Balendiran G.K., Dabur R., Fraser D. The role of glutathione in cancer. Cell Biochemistry and Function 2004, 22(6):343-352.
9. Bard S., Noel P., Chauvin F., Quash G. gamma-Glutamyltranspeptidase activity in human breast lesions: An unfavourable prognostic sign. British Journal of Cancer 1986, 53(5):637-642.
10. Barrios R., Shi Z.Z., Kala S.V., Wiseman A.L., Welty S.E., Kala G., et al. Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidase-deficient mice. Lung 2001, 179(5):319-330.
11. Benlloch M., Ortega A., Ferrer P., Segarra R., Obrador E., Asensi M., et al. Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity. The Journal of Biological Chemistry 2005, 280(8):6950-6959.
12. Biddle A., Gammon L., Fazil B., Mackenzie I.C. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition. PLoS One 2013, 8(2):e57314.
13. Binkley F., Nakamura K. Metabolism of glutathione; hydrolysis by tissues of the rat. The Journal of Biological Chemistry 1948, 173(1):411-421.
14. Blanco R.A., Ziegler T.R., Carlson B.A., Cheng P.Y., Park Y., Cotsonis G.A., et al. Diurnal variation in glutathione and cysteine redox states in human plasma. The American Journal of Clinical Nutrition 2007, 86(4):1016-1023.
15. Brannigan J.A., Dodson G., Duggleby H.J., Moody P.C., Smith J.L., Tomchick D.R., et al. A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature 1995, 378(6555):416-419.
16. Brouillet A., Darbouy M., Okamoto T., Chobert M.N., Lahuna O., Garlatti M., et al. Functional characterization of the rat gamma-glutamyl transpeptidase promoter that is expressed and regulated in the liver and hepatoma cells. The Journal of Biological Chemistry 1994, 269(21):14878-14884.
17. Butturini E., de Prati A.C., Chiavegato G., Rigo A., Cavalieri E., Darra E., et al. Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoral cells to chemotherapeutic drugs. Free Radical Biology and Medicine 2013, 65:1322-1330.
18. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nature Reviews. Cancer 2011, 11(2):85-95.
19. Calvert P., Yao K.S., Hamilton T.C., O'Dwyer P.J. Clinical studies of reversal of drug resistance based on glutathione. Chemico-Biological Interactions 1998, 111-112:213-224.
20. Cameron R.G., Armstrong D., Gunsekara A., Varghese G., Speisky H. Utilization of circulating glutathione by nodular and cancerous intact rat liver. Carcinogenesis 1991, 12(12):2369-2372.
21. Carter B.Z., Shi Z.Z., Barrios R., Lieberman M.W. gamma-Glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen. The Journal of Biological Chemistry 1998, 273(43):28277-28285.
22. Castonguay R., Halim D., Morin M., Furtos A., Lherbet C., Bonneil E., et al. Kinetic characterization and identification of the acylation and glycosylation sites of recombinant human gamma-glutamyltranspeptidase. Biochemistry 2007, 46(43):12253-12262.
23. Chaiswing L., Zhong W., Oberley T.D. Distinct redox profiles of selected human prostate carcinoma cell lines: Implications for rational design of redox therapy. Cancers 2011, 3(3):3557-3584.
24. Chaudhari P., Ye Z., Jang Y.Y. Roles of reactive oxygen species in the fate of stem cells. Antioxidants & Redox Signaling 2012, 20:1881-1890.
25. Chevez-Barrios P., Wiseman A.L., Rojas E., Ou C.N., Lieberman M.W. Cataract development in gamma-glutamyl transpeptidase-deficient mice. Experimental Eye Research 2000, 71(6):575-582.
26. Chikhi N., Holic N., Guellaen G., Laperche Y. Gamma-glutamyl transpeptidase gene organization and expression: A comparative analysis in rat, mouse, pig and human species. Comparative Biochemistry and Physiology. Part B, Biochemistry and Molecular Biology 1999, 122(4):367-380.
27. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biology & Medicine 2010, 48(6):749-762.
28. Cole S.P., Deeley R.G. Transport of glutathione and glutathione conjugates by MRP1. Trends in Pharmacological Sciences 2006, 27(8):438-446.
29. Cooper A.J.L., Hanigan M.H. Enzymes involved in processing glutathione conjugates. Comprehensive toxicology 2010, Vol. 4:323-366. Elsevier, Oxford, Chapter 17. C.A. McQueen (Ed.).
30. Corti A., Duarte T.L., Giommarelli C., De Tata V., Paolicchi A., Jones G.D., et al. Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells. Mutation Research 2009, 669(1-2):112-121.
31. Courtay C., Heisterkamp N., Siest G., Groffen J. Expression of multiple gamma-glutamyltransferase genes in man. The Biochemical Journal 1994, 297(Pt 3):503-508.
32. Crook T.R., Souhami R.L., Whyman G.D., McLean A.E. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Research 1986, 46(10):5035-5038.
33. Curthoys N.P., Hughey R.P. Characterization and physiological function of rat renal gamma-glutamyltranspeptidase. Enzyme 1979, 24(6):383-403.
34. Daubeuf S., Accaoui M.J., Pettersen I., Huseby N.E., Visvikis A., Galteau M.M. Differential regulation of gamma-glutamyltransferase mRNAs in four human tumour cell lines. Biochimica et Biophysica Acta 2001, 1568(1):67-73.
35. Davis S.R., Quinlivan E.P., Stacpoole P.W., Gregory J.F. Plasma glutathione and cystathionine concentrations are elevated but cysteine flux is unchanged by dietary vitamin B-6 restriction in young men and women. The Journal of Nutrition 2006, 136(2):373-378.
36. DeNicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475(7354):106-109.
37. Diederich M., Wellman M., Visvikis A., Puga A., Siest G. The 5' untranslated region of the human gamma-glutamyl transferase mRNA contains a tissue-specific active translational enhancer. FEBS Letters 1993, 332(1-2):88-92.
38. Dominici S., Valentini M., Maellaro E., Del Bello B., Paolicchi A., Lorenzini E., et al. Redox modulation of cell surface protein thiols in U937 lymphoma cells: The role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation. Free Radical Biology & Medicine 1999, 27(5-6):623-635.
39. Doxsee D.W., Gout P.W., Kurita T., Lo M., Buckley A.R., Wang Y., et al. Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy. Prostate 2007, 67(2):162-171.
40. Durham J.R., Frierson H.F., Hanigan M.H. Gamma-glutamyl transpeptidase immunoreactivity in benign and malignant breast tissue. Breast Cancer Research and Treatment 1997, 45(1):55-62.
41. Estrela J.M., Ortega A., Obrador E. Glutathione in cancer biology and therapy. Critical Reviews in Clinical Laboratory Sciences 2006, 43(2):143-181.
42. Fagoonee S., Bearzi C., Di Cunto F., Clohessy J.G., Rizzi R., Reschke M., et al. The RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cells. PLoS One 2013, 8(8):e72300.
43. Figlewicz D.A., Delattre O., Guellaen G., Krizus A., Thomas G., Zucman J., et al. Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. Genomics 1993, 17(2):299-305.
44. Forman H.J., Skelton D.C. Protection of alveolar macrophages from hyperoxia by gamma-glutamyl transpeptidase. The American Journal of Physiology 1990, 259(2 Pt 1):L102-L107.
45. Gallagher B.C., Rudolph D.B., Hinton B.T., Hanigan M.H. Differential induction of gamma-glutamyl transpeptidase in primary cultures of rat and mouse hepatocytes parallels induction during hepatocarcinogenesis. Carcinogenesis 1998, 19(7):1251-1255.
46. Galperin M.Y., Koonin E.V. Divergence and convergence in enzyme evolution. The Journal of Biological Chemistry 2012, 287(1):21-28.
47. Glass G.A., Stark A.A. Promotion of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by copper and ceruloplasmin: The requirement for iron and the effects of antioxidants and antioxidant enzymes. Environmental and Molecular Mutagenesis 1997, 29(1):73-80.
48. Go Y.M., Jones D.P. Thiol/disulfide redox states in signaling and sensing. Critical Reviews in Biochemistry and Molecular Biology 2013, 48(2):173-181.
49. Godwin A.K., Meister A., O'Dwyer P.J., Huang C.S., Hamilton T.C., Anderson M.E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(7):3070-3074.
50. Goldsworthy T.L., Hanigan M.H., Pitot H.C. Models of hepatocarcinogenesis in the rat-Contrasts and comparisons. Critical Reviews in Toxicology 1986, 17(1):61-89.
51. Ahluwalia G.S., Grem J.L., Hao Z., Cooney D.A. Metabolism and action of amino acid analog anti-cancer agents. Pharmacology & Therapeutics 1990, 46(2):243-271.
52. Griffith O.W., Meister A. Translocation of intracellular glutathione to membrane-bound gamma-glutamyl transpeptidase as a discrete step in the gamma-glutamyl cycle: Glutathionuria after inhibition of transpeptidase. Proceedings of the National Academy of Sciences of the United States of America 1979, 76(1):268-272.
53. Grimm C., Hofstetter G., Aust S., Mutz-Dehbalaie I., Bruch M., Heinze G., et al. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer. British Journal of Cancer 2013, 109(3):610-614.
54. Hamaguchi K., Godwin A.K., Yakushiji M., O'Dwyer P.J., Ozols R.F., Hamilton T.C. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Research 1993, 53(21):5225-5232.
55. Han L., Hiratake J., Kamiyama A., Sakata K. Design, synthesis, and evaluation of gamma-phosphono diester analogues of glutamate as highly potent inhibitors and active site probes of gamma-glutamyl transpeptidase. Biochemistry 2007, 46(5):1432-1447.
56. Hanes C.S., Hird F.J., Isherwood F.A. Enzymic transpeptidation reactions involving gamma-glutamyl peptides and alpha-amino-acyl peptides. The Biochemical Journal 1952, 51(1):25-35.
57. Hanigan M.H. Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis 1995, 16(2):181-185.
58. Hanigan M.H., Brown J.E., Ricketts W.A. Gamma-glutamyl transpeptidase, a glutathionase, is present in some cell culture grade bovine sera. In Vitro Cellular Developmental Biology Animal 1993, 29A(11):831-833.
59. Hanigan M.H., Frierson H.F. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. The Journal of Histochemistry and Cytochemistry 1996, 44(10):1101-1108.
60. Hanigan M.H., Frierson H.F., Brown J.E., Lovell M.A., Taylor P.T. Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Research 1994, 54(1):286-290.
61. Hanigan M.H., Frierson H.F., Swanson P.E., De Young B.R. Altered expression of gamma-glutamyl transpeptidase in human tumors. Human Pathology 1999, 30(3):300-305.
62. Hanigan M.H., Frierson H.F., Taylor P.T. Expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy. American Journal of Obstetrics and Gynecology 1998, 179(2):363-367.
63. Hanigan M.H., Gallagher B.C., Taylor P.T., Large M.K. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Research 1994, 54(22):5925-5929.
64. Hanigan M.H., Gallagher B.C., Townsend D.M., Gabarra V. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 1999, 20(4):553-559.
65. Hanigan H.M., Laishes B.A. Toxicity of aflatoxin B1 in rat and mouse hepatocytes in vivo and in vitro. Toxicology 1984, 30(3):185-193.
66. Hanigan M.H., Lykissa E.D., Townsend D.M., Ou C.N., Barrios R., Lieberman M.W. Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. The American Journal of Pathology 2001, 159(5):1889-1894.
67. Hanigan M.H., Pitot H.C. Activities of benzphetamine N-demethylase and aryl hydrocarbon hydroxylase in cells isolated from gamma-glutamyl transpeptidase-positive foci and surrounding liver. Journal of the National Cancer Institute 1985, 75(6):1107-1112.
68. Hanigan M.H., Pitot H.C. Gamma-glutamyl transpeptidase-Its role in hepatocarcinogenesis. Carcinogenesis 1985, 6(2):165-172.
69. Hanigan M.H., Ricketts W.A. Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 1993, 32(24):6302-6306.
70. Hanigan M.H., Winkler M.L., Drinkwater N.R. Induction of three histochemically distinct populations of hepatic foci in C57BL/6J mice. Carcinogenesis 1993, 14(5):1035-1040.
71. Harding C.O., Williams P., Wagner E., Chang D.S., Wild K., Colwell R.E., et al. Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility. The Journal of Biological Chemistry 1997, 272(19):12560-12567.
72. Hayes J.D., Judah D.J., Neal G.E., Nguyen T. Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide. The Biochemical Journal 1992, 285(Pt 1):173-180.
73. Heisterkamp N., Groffen J., Warburton D., Sneddon T.P. The human gamma-glutamyltransferase gene family. Human Genetics 2008, 123(4):321-332.
74. Heisterkamp N., Rajpert-De Meyts E., Uribe L., Forman H.J., Groffen J. Identification of a human gamma-glutamyl cleaving enzyme related to, but distinct from, gamma-glutamyl transpeptidase. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(14):6303-6307.
75. Hidalgo M., Rodriguez G., Kuhn J.G., Brown T., Weiss G., MacGovren J.P., et al. A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies. Clinical Cancer Research 1998, 4(11):2763-2770.
76. Hochwald S.N., Harrison L.E., Rose D.M., Anderson M., Burt M.E. gamma-Glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. Journal of the National Cancer Institute 1996, 88(3-4):193-197.
77. Hochwald S.N., Rose D.M., Brennan M.F., Burt M.E. Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma. Annals of Surgical Oncology 1997, 4(4):303-309.
78. Huseby N.E., Asare N., Wetting S., Mikkelsen I.M., Mortensen B., Wellman M. Role of gamma-glutamyltransferase in the homeostasis of glutathione during oxidative and nitrosative stress. Biofactors 2003, 17(1-4):151-160.
79. Ikeda Y., Fujii J., Taniguchi N., Meister A. Expression of an active glycosylated human gamma-glutamyl transpeptidase mutant that lacks a membrane anchor domain. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(1):126-130.
80. Ishimoto T., Nagano O., Yae T., Tamada M., Motohara T., Oshima H., et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011, 19(3):387-400.
81. Jean J.C., Liu Y., Brown L.A., Marc R.E., Klings E., Joyce-Brady M. Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. American Journal of Physiology. Lung Cellular and Molecular Physiology 2002, 283(4):L766-L776.
82. Jones D.P. Redox sensing: Orthogonal control in cell cycle and apoptosis signalling. Journal of Internal Medicine 2010, 268(5):432-448.
83. Joyce-Brady M., Jean J.C., Hughey R.P. gamma -glutamyltransferase and its isoform mediate an endoplasmic reticulum stress response. The Journal of Biological Chemistry 2001, 276(12):9468-9477.
84. Kang J.S., Wanibuchi H., Morimura K., Wongpoomchai R., Chusiri Y., Gonzalez F.J., et al. Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. Toxicology and Applied Pharmacology 2008, 228(3):295-300.
85. Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biology 2013, 1(1):45-49.
86. Karp D.R., Shimooku K., Lipsky P.E. Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. The Journal of Biological Chemistry 2001, 276(6):3798-3804.
87. Keillor J.W., Castonguay R., Lherbet C. Gamma-glutamyl transpeptidase substrate specificity and catalytic mechanism. Methods in Enzymology 2005, 401:449-467.
88. King J.B., West M.B., Cook P.F., Hanigan M.H. A novel, species-specific class of uncompetitive inhibitors of gamma-glutamyl transpeptidase. The Journal of Biological Chemistry 2009, 284(14):9059-9065.
89. Kinoshita H., Okabe H., Beppu T., Chikamoto A., Hayashi H., Imai K., et al. Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma. Oncology Reports 2013, 29(2):685-689.
90. Knickelbein R.G., Ingbar D.H., Seres T., Snow K., Johnston R.B., Fayemi O., et al. Hyperoxia enhances expression of gamma-glutamyl transpeptidase and increases protein S-glutathiolation in rat lung. The American Journal of Physiology 1996, 270(1 Pt 1):L115-L122.
91. Kobata A., Amano J. Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunology and Cell Biology 2005, 83(4):429-439.
92. Kojima J., Kanatani M., Nakamura N., Kashiwagi T., Tohjoh F., Akiyama M. Electrophoretic fractionation of serum gamma-glutamyl transpeptidase in human hepatic cancer. Clinica Chimica Acta 1980, 106(2):165-172.
93. Kwiecien I., Rokita H., Lorenc-Koci E., Sokolowska M., Wlodek L. The effect of modulation of gamma-glutamyl transpeptidase and nitric oxide synthase activity on GSH homeostasis in HepG2 cells. Fundamental & Clinical Pharmacology 2007, 21(1):95-103.
94. Lauterburg B.H., Adams J.D., Mitchell J.R. Hepatic glutathione homeostasis in the rat: Efflux accounts for glutathione turnover. Hepatology 1984, 4(4):586-590.
95. Lewerenz J., Hewett S.J., Huang Y., Lambros M., Gout P.W., Kalivas P.W., et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: From molecular mechanisms to novel therapeutic opportunities. Antioxidants & Redox Signaling 2013, 18(5):522-555.
96. Lewis A.D., Hayes J.D., Wolf C.R. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: Intrinsic differences and cell cycle effects. Carcinogenesis 1988, 9(7):1283-1287.
97. Lieberman M.W., Barrios R., Carter B.Z., Habib G.M., Lebovitz R.M., Rajagopalan S., et al. gamma-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions?. The American Journal of Pathology 1995, 147(5):1175-1185.
98. Lieberman M.W., Wiseman A.L., Shi Z.Z., Carter B.Z., Barrios R., Ou C.N., et al. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(15):7923-7926.
99. Maciag A.E., Holland R.J., Robert Cheng Y.S., Rodriguez L.G., Saavedra J.E., Anderson L.M., et al. Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance. Redox Biology 2013, 1(1):115-124.
100. Mandel H.G., Manson M.M., Judah D.J., Simpson J.L., Green J.A., Forrester L.M., et al. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat. Cancer Research 1987, 47(19):5218-5223.
101. Meister A. On the enzymology of amino acid transport. Science 1973, 180(4081):33-39.
102. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacology & Therapeutics 1991, 51(2):155-194.
103. Meredith M.J. Cystathionase activity and glutathione metabolism in redifferentiating rat hepatocyte primary cultures. Cell Biology and Toxicology 1987, 3(4):361-377.
104. Mikkelsen I.M., Mortensen B., Laperche Y., Huseby N.E. The expression of gamma-glutamyltransferase in rat colon carcinoma cells is distinctly regulated during differentiation and oxidative stress. Molecular and Cellular Biochemistry 2002, 232(1-2):87-95.
105. Mistry P., Harrap K.R. Historical aspects of glutathione and cancer chemotherapy. Pharmacology & Therapeutics 1991, 49(1-2):125-132.
106. 2-induced apoptosis via upregulation of gamma-glutamyltransferase-2. Toxicology In Vitro 2012, 26(3):429-434.
107. Moriarty-Craige S.E., Jones D.P. Extracellular thiols and thiol/disulfide redox in metabolism. Annual Review of Nutrition 2004, 24:481-509.
108. Morris C., Courtay C., Geurts van Kessel A., ten Hoeve J., Heisterkamp N., Groffen J. Localization of a gamma-glutamyl-transferase-related gene family on chromosome 22. Human Genetics 1993, 91(1):31-36.
109. Morrow A.L., Williams K., Sand A., Boanca G., Barycki J.J. Characterization of Helicobacter pylori gamma-glutamyltranspeptidase reveals the molecular basis for substrate specificity and a critical role for the tyrosine 433-containing loop in catalysis. Biochemistry 2007, 46(46):13407-13414.
110. Nagano O., Okazaki S., Saya H. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 2013, 32:5191-5198.
111. Nakagawa Y., Suzuki T., Nakajima K., Ishii H., Ogata A. Biotransformation and cytotoxic effects of hydroxychavicol, an intermediate of safrole metabolism, in isolated rat hepatocytes. Chemico-Biological Interactions 2009, 180(1):89-97.
112. Newkirk K., Heffern J., Sloman-Moll E., Sessions R.B., Rasmussen A.A., Andrews P.A., et al. Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines. Cancer Chemother Pharmacol 1997, 40(1):75-80.
113. Oguchi H., Kikkawa F., Kojima M., Maeda O., Mizuno K., Suganuma N., et al. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells. Anticancer Research 1994, 14(1A):193-200.
114. Oinonen C., Rouvinen J. Structural comparison of Ntn-hydrolases. Protein Science 2000, 9(12):2329-2337.
115. Okada T., Suzuki H., Wada K., Kumagai H., Fukuyama K. Crystal structures of gamma-glutamyltranspeptidase from Escherichia coli, a key enzyme in glutathione metabolism, and its reaction intermediate. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(17):6471-6476.
116. Orlowski M., Meister A. gamma-Glutamyl-p-nitroanilide: A new convenient substrate for determination and study of L- and D-gamma-glutamyltranspeptidase activities. Biochimica et Biophysica Acta 1963, 73:679-681.
117. Orlowski M., Meister A. The gamma-glutamyl cycle: A possible transport system for amino acids. Proceedings of the National Academy of Sciences of the United States of America 1970, 67(3):1248-1255.
118. Ortega A.L., Salvador M., Estrela J.M. Glutathione in cancer cell death. Cancers 2011, 3:1285-1310.
119. Pandur S., Pankiv S., Johannessen M., Moens U., Huseby N.E. Gamma-glutamyltransferase is upregulated after oxidative stress through the Ras signal transduction pathway in rat colon carcinoma cells. Free Radical Research 2007, 41(12):1376-1384.
120. Pani G., Galeotti T., Chiarugi P. Metastasis: Cancer cell's escape from oxidative stress. Cancer Metastasis Reviews 2010, 29(2):351-378.
121. Pankiv S., Moller S., Bjorkoy G., Moens U., Huseby N.E. Radiation-induced upregulation of gamma-glutamyltransferase in colon carcinoma cells is mediated through the Ras signal transduction pathway. Biochimica et Biophysica Acta 2006, 1760(2):151-157.
122. Paolicchi A., Emdin M., Passino C., Lorenzini E., Titta F., Marchi S., et al. Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006, 186(1):80-85.
123. Pardo A., Ruiz V., Arreola J.L., Ramirez R., Cisneros-Lira J., Gaxiola M., et al. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. American Journal of Respiratory and Critical Care Medicine 2003, 167(6):925-932.
124. PetitClerc C., Shiele F., Bagrel D., Mahassen A., Siest G. Kinetic properties of gamma-glutamyltransferase from human liver. Clinical Chemistry 1980, 26(12):1688-1693.
125. Pham A.N., Blower P.E., Alvarado O., Ravula R., Gout P.W., Huang Y. Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines. The Journal of Pharmacology and Experimental Therapeutics 2010, 332(3):949-958.
126. Rajpert-De Meyts E., Heisterkamp N., Groffen J. Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. Proceedings of the National Academy of Sciences of the United States of America 1988, 85(23):8840-8844.
127. Rajpert-De Meyts E., Shi M., Chang M., Robison T.W., Groffen J., Heisterkamp N., et al. Transfection with gamma-glutamyl transpeptidase enhances recovery from glutathione depletion using extracellular glutathione. Toxicology and Applied Pharmacology 1992, 114(1):56-62.
128. Rao M.S., Lalwani N.D., Scarpelli D.G., Reddy J.K. The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643. Carcinogenesis 1982, 3(10):1231-1233.
129. Ravuri C., Svineng G., Pankiv S., Huseby N.E. Endogenous production of reactive oxygen species by the NADPH oxidase complexes is a determinant of gamma-glutamyltransferase expression. Free Radical Research 2011, 45(5):600-610.
130. Reuter S., Schnekenburger M., Cristofanon S., Buck I., Teiten M.H., Daubeuf S., et al. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochemical Pharmacology 2009, 77(3):397-411.
131. Ripple M.O., Henry W.F., Rago R.P., Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. Journal of the National Cancer Institute 1997, 89(1):40-48.
132. Robe P.A., Martin D.H., Nguyen-Khac M.T., Artesi M., Deprez M., Albert A., et al. Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer 2009, 9:372.
133. Rojas E., Valverde M., Kala S.V., Kala G., Lieberman M.W. Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. Mutation Research 2000, 447(2):305-316.
134. Roomi M.W., Gaal K., Yuan Q.X., French B.A., Fu P., Bardag-Gorce F., et al. Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice. Experimental and Molecular Pathology 2006, 81(1):8-14.
135. Rosalki S.B. Gamma-glutamyl transpeptidase. Advances in Clinical Chemistry 1975, 17:53-107.
136. Ruoso P., Hedley D.W. Inhibition of gamma-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma. Cancer Chemotherapy and Pharmacology 2004, 54(1):49-56.
137. Sawabu N., Nakagen M., Ozaki K., Wakabayashi T., Toya D., Hattori N., et al. Clinical evaluation of specific gamma-GTP isoenzyme in patients with hepatocellular carcinoma. Cancer 1983, 51(2):327-331.
138. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biology & Medicine 2001, 30(11):1191-1212.
139. Schulman J.D., Goodman S.I., Mace J.W., Patrick A.D., Tietze F., Butler E.J. Glutathionuria: Inborn error of metabolism due to tissue deficiency of gamma-glutamyl transpeptidase. Biochemical and Biophysical Research Communications 1975, 65(1):68-74.
140. Scopelliti A.J., Ryan R.M., Vandenberg R.J. Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members. The Journal of Biological Chemistry 2013, 288(12):8250-8257.
141. Shi M., Gozal E., Choy H.A., Forman H.J. Extracellular glutathione and gamma-glutamyl transpeptidase prevent H2O2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Radical Biology & Medicine 1993, 15(1):57-67.
142. Shi Z.Z., Han B., Habib G.M., Matzuk M.M., Lieberman M.W. Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response. Molecular and Cellular Biology 2001, 21(16):5389-5395.
143. Sies H., Bartoli G.M., Burk R.F., Waydhas C. Glutathione efflux from perfused rat liver after phenobarbital treatment, during drug oxidations, and in selenium deficiency. European Journal of Biochemistry 1978, 89(1):113-118.
144. Slaga T.J., Budunova I.V., Gimenez-Conti I.B., Aldaz C.M. The mouse skin carcinogenesis model. The Journal of Investigative Dermatology. Symposium Proceedings 1996, 1(2):151-156.
145. Stark A.A., Russell J.J., Langenbach R., Pagano D.A., Zeiger E., Huberman E. Localization of oxidative damage by a glutathione-gamma-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats. Carcinogenesis 1994, 15(2):343-348.
146. Stark A.A., Zeiger E., Pagano D.A. Glutathione metabolism by gamma-glutamyltranspeptidase leads to lipid peroxidation: Characterization of the system and relevance to hepatocarcinogenesis. Carcinogenesis 1993, 14(2):183-189.
147. Stenius U., Rubin K., Gullberg D., Hogberg J. gamma-Glutamyltranspeptidase-positive rat hepatocytes are protected from GSH depletion, oxidative stress and reversible alterations of collagen receptors. Carcinogenesis 1990, 11(1):69-73.
148. Takahashi Y., Oakes S.M., Williams M.C., Takahashi S., Miura T., Joyce-Brady M. Nitrogen dioxide exposure activates gamma-glutamyl transferase gene expression in rat lung. Toxicology and Applied Pharmacology 1997, 143(2):388-396.
149. Takahashi Y., Takahashi S., Yoshimi T., Miura T., Mochitate K., Kobayashi T. Increases in the mRNA levels of gamma-glutamyltransferase and heme oxygenase-1 in the rat lung after ozone exposure. Biochemical Pharmacology 1997, 53(7):1061-1064.
150. Takeuchi S., Wada K., Toyooka T., Shinomiya N., Shimazaki H., Nakanishi K., et al. Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. Neurosurgery 2013, 72(1):33-41. discussion 41.
151. Tate S.S., Meister A. Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase. Proceedings of the National Academy of Sciences of the United States of America 1978, 75(10):4806-4809.
152. Tateishi N., Higashi T., Nomura T., Naruse A., Nakashima K. Higher transpeptidation activity and broad acceptor specificity of gamma-glutamyltransferases of tumors. Gann 1976, 67(2):215-222.
153. Tew K.D., Townsend D.M. Glutathione-s-transferases as determinants of cell survival and death. Antioxidants & Redox Signaling 2012, 17(12):1728-1737.
154. Townsend D.M., Deng M., Zhang L., Lapus M.G., Hanigan M.H. Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. Journal of the American Society of Nephrology 2003, 14(1):1-10.
155. Townsend D.M., Hanigan M.H. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. The Journal of Pharmacology and Experimental Therapeutics 2002, 300(1):142-148.
156. Traverso N., Ricciarelli R., Nitti M., Marengo B., Furfaro A.L., Pronzato M.A., et al. Role of glutathione in cancer progression and chemoresistance. Oxidative Medicine and Cellular Longevity 2013, 2013:972913.
157. Vassallo J.D., Hicks S.M., Born S.L., Daston G.P. Roles for epoxidation and detoxification of coumarin in determining species differences in clara cell toxicity. Toxicological Sciences 2004, 82(1):26-33.
158. Vassallo J.D., Kaetzel R.S., Born S.L., Lewis C.L., Lehman-McKeeman L.D., Reed D.J. Gamma-glutamyl transpeptidase null mice fail to develop tolerance to coumarin-induced Clara cell toxicity. Food and Chemical Toxicology 2010, 48(6):1612-1618.
159. Vene R., Castellani P., Delfino L., Lucibello M., Ciriolo M.R., Rubartelli A. The cystine/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets. Antioxidants & Redox Signaling 2011, 15(9):2439-2453.
160. Vina J., Perez C., Furukawa T., Palacin M., Vina J.R. Effect of oral glutathione on hepatic glutathione levels in rats and mice. The British Journal of Nutrition 1989, 62(3):683-691.
161. Visvikis A., Pawlak A., Accaoui M.J., Ichino K., Leh H., Guellaen G., et al. Structure of the 5' sequences of the human gamma-glutamyltransferase gene. European Journal of Biochemistry 2001, 268(2):317-325.
162. Warren D.L., Brown D.L., Buckpitt A.R. Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. Chemico-Biological Interactions 1982, 40(3):287-303.
163. Warzecha C.C., Shen S., Xing Y., Carstens R.P. The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biology 2009, 6(5):546-562.
164. West M.B., Chen Y., Wickham S., Heroux A., Cahill K., Hanigan M.H., et al. Novel insights into eukaryotic gamma-glutamyl transpeptidase 1 from the crystal structure of the glutamate-bound human enzyme. The Journal of Biological Chemistry 2013, 288(44):31902-31913.
165. West M.B., Segu Z.M., Feasley C.L., Kang P., Klouckova I., Li C., et al. Analysis of site-specific glycosylation of renal and hepatic gamma-glutamyl transpeptidase from normal human tissue. The Journal of Biological Chemistry 2010, 285(38):29511-29524.
166. West M.B., Wickham S., Parks E.E., Sherry D.M., Hanigan M.H. Human GGT2 Does Not Autocleave into a Functional Enzyme: A Cautionary Tale for Interpretation of Microarray Data on Redox Signaling. Antioxidants & Redox Signaling 2013, 19(16):1877-1888.
167. West M.B., Wickham S., Quinalty L.M., Pavlovicz R.E., Li C., Hanigan M.H. Autocatalytic cleavage of human {gamma}-glutamyl transpeptidase is highly dependent on N-glycosylation at asparagine 95. The Journal of Biological Chemistry 2011, 286(33):28876-28888.
168. Whitfield J.B. Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences 2001, 38(4):263-355.
169. Wickham S., Regan N., West M.B., Kumar V.P., Thai J., Li P.K., et al. Divergent effects of compounds on the hydrolysis and transpeptidation reactions of gamma-glutamyl transpeptidase. Journal of Enzyme Inhibition and Medicine Chemistry 2011, 27:476-489.
170. Wickham S., Regan N., West M.B., Thai J., Cook P.F., Terzyan S.S., et al. Inhibition of human gamma-glutamyl transpeptidase: Development of more potent, physiologically relevant, uncompetitive inhibitors. The Biochemical Journal 2013, 450(3):547-557.
171. Wickham S., West M.B., Cook P.F., Hanigan M.H. Gamma-glutamyl compounds: Substrate specificity of gamma-glutamyl transpeptidase enzymes. Analytical Biochemistry 2011, 414:208-214.
172. Williams G.M., Ohmori T., Katayama S., Rice J.M. Alteration by phenobarbital of membrane-associated enzymes including gamma glutamyl transpeptidase in mouse liver neoplasms. Carcinogenesis 1980, 1(10):813-818.
173. Woodlock T.J., Brown R., Mani M., Pompeo L., Hoffman H., Segel G.B., et al. Decreased L system amino acid transport and decreased gamma-glutamyl transpeptidase are independent processes in human chronic lymphocytic leukemia B-lymphocytes. Journal of Cellular Physiology 1990, 145(2):217-221.
174. Wright E.C., Stern J., Ersser R., Patrick A.D. Glutathionuria: Gamma-glutamyl transpeptidase deficiency. Journal of Inherited Metabolic Disease 1980, 2(1):3-7.
175. Xiong Y., Uys J.D., Tew K.D., Townsend D.M. S-glutathionylation: From molecular mechanisms to health outcomes. Antioxidants & Redox Signaling 2011, 15(1):233-270.
176. Xu K., Meng X.Y., Wu J.W., Shen B., Shi Y.C., Wei Q. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: A 10-year study. The American Journal of Gastroenterology 1992, 87(8):991-995.
177. Yamada K., Tsuji T., Kunieda T. Phenotypic characterization of Ggt1(dwg/dwg) mice, a mouse model for hereditary gamma-glutamyltransferase deficiency. Experimental Animals 2013, 62(2):151-157.
178. Yamamoto S., Watanabe B., Hiratake J., Tanaka R., Ohkita M., Matsumura Y. Preventive effect of GGsTop, a novel and selective gamma-glutamyl transpeptidase inhibitor, on ischemia/reperfusion-induced renal injury in rats. The Journal of Pharmacology and Experimental Therapeutics 2011, 339(3):945-951.
179. Yang L., Fox S.A., Kirby J.L., Troan B.V., Hinton B.T. Putative regulation of expression of members of the Ets variant 4 transcription factor family and their downstream targets in the rat epididymis. Biology of Reproduction 2006, 74(4):714-720.
180. Yao D.F., Huang Z.W., Chen S.Z., Huang J.F., Lu J.X., Xiao M.B., et al. Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase. American Journal of Clinical Pathology 1998, 110(6):743-749.
181. Yoshikawa M., Tsuchihashi K., Ishimoto T., Yae T., Motohara T., Sugihara E., et al. xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Research 2013, 73(6):1855-1866.